Industrial nanoparticle application : representative survey among Swiss companies shows low usage and basic protection means

Détails

ID Serval
serval:BIB_E13388E84A7C
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Institution
Titre
Industrial nanoparticle application : representative survey among Swiss companies shows low usage and basic protection means
Titre de la conférence
American Thoracic Society 2009 International Conference, May 15-20, 2009, San Diego, California
Auteur⸱e⸱s
Schmid Kaspar, Danuser Brigitta, Riediker Michael
ISBN
1073-449X
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
179
Série
American Journal of Respiratory and Critical Care Medicine
Pages
A5264
Langue
anglais
Notes
SAPHIRID:80481
Résumé
Manufactured nanoparticles are introduced into industrial processes, but they are suspected to cause similar negative health effects as ambient particles. The poor knowledge about the scale of this introduction did not allow global risk analysis so far. In 2006 a targeted telephone survey among Swiss companies (1) showed the usage of nanoparticles in a few selected companies but did not provide data to extrapolate on the totality of the Swiss workforce. To gain this kind of information a layered representative questionnaire survey among 1'626 Swiss companies was conducted in 2007. Data was collected about the number of potentially exposed persons in the companies and their protection strategy. The response rate was 58.3%. An expected number of 586 companies (95%−confidence interval 145 to 1'027) was shown by this study to use nanoparticles in Switzerland. Estimated 1'309 (1'073 to 1'545) workers do their job in the same room as a nanoparticle application. Personal protection was shown to be the predominant type of protection means. Companies starting productions with nanomaterials need to consider incorporating protection measures into the plans. This will not only benefit the workers' health, but will also likely increase the competitiveness of the companies. Technical and organisational protection means are not only more cost−effective on the long term, but are also easier to control. Guidelines may have to be designed specifically for different industrial applications, including fields outside nanotechnology, and adapted to all sizes of companies.
Mots-clé
Nanoparticles , Occupational Exposure , Occupational Health , Industry , Data Collection
Création de la notice
27/01/2010 13:20
Dernière modification de la notice
20/08/2019 17:05
Données d'usage